← Back to Search

OCT for Normal Eyes

N/A
Waitlist Available
Research Sponsored by Optos, PLC
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 year
Awards & highlights

Study Summary

This trial aims to create a database of eye scans for use in medical research and diagnosis.

Who is the study for?
This trial is for people who are at least 22 years old, can follow the study's procedures, and have signed the consent form. They must have normal eyes with a visual acuity of 20/40 or better but can have certain conditions like cataracts or past eye surgeries that don't affect the back part of the eye.Check my eligibility
What is being tested?
The study aims to gather data using Optical Coherence Tomography (OCT) on participants with normal eyesight to create a reference database for a device called P200TE.See study design
What are the potential side effects?
Since this trial involves non-invasive imaging with OCT and does not test any drugs or invasive treatments, there are no expected side effects related to medications. However, discomfort from bright lights during imaging may occur.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 year
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 year for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
GCC Thickness
Optic Nerve Head
RNFL Thickness
+1 more
Secondary outcome measures
Adverse Events

Trial Design

1Treatment groups
Experimental Treatment
Group I: OCTExperimental Treatment1 Intervention
Device: P200TE The P200TE provides OCT imaging including retina topography and ONH (optic nerve head) scans.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
P200TE
2019
N/A
~370

Find a Location

Who is running the clinical trial?

Optos, PLCLead Sponsor
17 Previous Clinical Trials
2,715 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the geographical scope of this clinical study?

"This research has 8 participating sites, such as Specialty Eye Care Centre in Bellevue, Eyecare of San Diego in San Diego and Marshall B Ketchum University's Southern California College of Optometry located in Roslindale. In addition to these 3 institutions, there are 5 other places undertaking the study."

Answered by AI

Are new participants enrolling in this experiment?

"According to information available on clinicaltrials.gov, this medical examination is actively enrolling subjects since it was posted in March 14th of 2023 and last updated on May 2nd of the same year."

Answered by AI

How many subjects are enrolled in this research protocol?

"Correct. Clinicaltrials.gov affirms that this medical experiment, which launched on March 14th 2023, is actively recruiting patients. The study has a target of 800 participants across 8 locations."

Answered by AI

Who else is applying?

What state do they live in?
California
What site did they apply to?
Marshall B Ketchum University, Southern California College of Optometry
What portion of applicants met pre-screening criteria?
Met criteria
How many prior treatments have patients received?
0

What questions have other patients asked about this trial?

How long does the clinic visit take and how much do we get paid? Also do we need to bring anything?
PatientReceived 1 prior treatment

Why did patients apply to this trial?

I am curious to see what this trial is mainly about.
PatientReceived 2+ prior treatments
~0 spots leftby May 2024